These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30195440)

  • 21. Use of Telemedicine to Enhance Pharmacist Services in the Nursing Facility.
    Kane-Gill SL; Niznik JD; Kellum JA; Culley CM; Boyce RD; Marcum ZA; He H; Perera S; Handler SM
    Consult Pharm; 2017 Feb; 32(2):93-98. PubMed ID: 28569660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Models for pharmacist-delivered tobacco cessation services: a systematic review.
    O'Reilly E; Frederick E; Palmer E
    J Am Pharm Assoc (2003); 2019; 59(5):742-752. PubMed ID: 31307963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A survey to assess the availability, implementation rate and remuneration of pharmacist-led cognitive services throughout Europe.
    Soares IB; Imfeld-Isenegger TL; Makovec UN; Horvat N; Kos M; Arnet I; Hersberger KE; Costa FA
    Res Social Adm Pharm; 2020 Jan; 16(1):41-47. PubMed ID: 30737196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Key factors for sustainable integration of pharmacists in team-based primary care physician practices.
    Dombrowski SK; Bacci JL; Klatt PM; Osborne M; Castelli G; Burns A; Somma McGivney MA
    J Am Pharm Assoc (2003); 2019; 59(3):439-448.e1. PubMed ID: 30982772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Billing for pharmacists' cognitive services in physicians' offices: multiple methods of reimbursement.
    Scott MA; Hitch WJ; Wilson CG; Lugo AM
    J Am Pharm Assoc (2003); 2012; 52(2):175-80. PubMed ID: 22370380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role and impact of pharmacists in Spain: a scoping review.
    Saavedra-Mitjans M; Ferrand É; Garin N; Bussières JF
    Int J Clin Pharm; 2018 Dec; 40(6):1430-1442. PubMed ID: 30367376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Analysis and Comparison of Medication Therapy Management Cost-Avoidance vs. Fee-for-Service Financial Models.
    Schuh MJ
    Consult Pharm; 2015 May; 30(5):291-7. PubMed ID: 25979129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pay-for-performance model of medication therapy management in pharmacy practice.
    Lenz TL; Monaghan MS
    J Am Pharm Assoc (2003); 2011; 51(3):425-31. PubMed ID: 21555297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expanding the roles of outpatient pharmacists: effects on health services utilisation, costs, and patient outcomes.
    Bero LA; Mays NB; Barjesteh K; Bond C
    Cochrane Database Syst Rev; 2000; (2):CD000336. PubMed ID: 10796529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic evaluations of clinical pharmacy services: 2006-2010.
    Touchette DR; Doloresco F; Suda KJ; Perez A; Turner S; Jalundhwala Y; Tangonan MC; Hoffman JM
    Pharmacotherapy; 2014 Aug; 34(8):771-93. PubMed ID: 24644086
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Understanding pharmacist success in practice: A scoping review.
    Dikun JA; Crumby AS; Shahpurwala Z; Hall J; Charrois TL; Rosenthal MM
    J Am Pharm Assoc (2003); 2016; 56(6):649-655. PubMed ID: 27692869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacists' acceptable levels of compensation for MTM services: a conjoint analysis.
    Wang J; Hong SH; Meng S; Brown LM
    Res Social Adm Pharm; 2011 Dec; 7(4):383-95. PubMed ID: 21272533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacist-participated medication review in different practice settings: Service or intervention? An overview of systematic reviews.
    Silva ROS; Macêdo LA; Santos GAD; Aguiar PM; de Lyra DP
    PLoS One; 2019; 14(1):e0210312. PubMed ID: 30629654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Billing for cognitive services: understanding Québec pharmacists' behavior.
    Kröger E; Moisan J; Grégoire JP
    Ann Pharmacother; 2000 Mar; 34(3):309-16. PubMed ID: 10917375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Getting Paid for Clinical Services.
    Martin CM
    Consult Pharm; 2018 May; 33(5):240-246. PubMed ID: 29789045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A systematic review and meta-analysis of pharmacist-led fee-for-services medication review.
    Hatah E; Braund R; Tordoff J; Duffull SB
    Br J Clin Pharmacol; 2014 Jan; 77(1):102-15. PubMed ID: 23594037
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacists remuneration models in iran and selected countries: a comparative study.
    Hashemi-Meshkini A; Keshavarz K; Nikfar S; Vazirian I; Kebriaeezadeh A
    Iran J Pharm Res; 2013; 12(4):995-64. PubMed ID: 24523777
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cooperation according to French Law "hospital, patients, health and territories": Pharmacists' involvement in Aquitaine region].
    d'Elbée M; Baumevieille M; Dumartin C
    Rev Epidemiol Sante Publique; 2017 Jun; 65(3):231-239. PubMed ID: 28262371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathway to pharmacist medical provider status in Washington State.
    Hazlet TK; Karwaki TE; Downing DF
    J Am Pharm Assoc (2003); 2017; 57(1):116-119. PubMed ID: 27836482
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Community Pharmacists' Contribution to Medication Reviews for Older Adults: A Systematic Review.
    Kallio SE; Kiiski A; Airaksinen MSA; Mäntylä AT; Kumpusalo-Vauhkonen AEJ; Järvensivu TP; Pohjanoksa-Mäntylä MK
    J Am Geriatr Soc; 2018 Aug; 66(8):1613-1620. PubMed ID: 29972691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.